Ken Colley Email and Phone Number
Ken Colley work email
- Valid
- Valid
- Valid
- Valid
Ken Colley personal email
- Valid
I am in the business of developing meaningful clinical data.Experienced MD/PhD physician-scientist-entrepreneur developing therapeutic products, clinical breakthroughs, alliances, and new ventures in the healthcare and greater biosciences industries for for more than two decades.• BioPharma/Biotech/Medtech/Nutratech product development and translational medicine expert, successfully advancing life-changing healthcare projects forward from R&D through human proof-of-concept mid-stage clinical studies [see "Specialities" below].• Successful development experience with small and large molecule biopharma drugs, and gene and cell biotherapies, including preclinical, translational, and clinical development studies. Expertise with new therapeutic products at the opportunity-rich convergence of biotech and medtech (medical devices) at innovative young companies.• Integrative Health Practitioner, licensed physician offering regenerative medicine therapies and precision/personalized healthcare treatments.Specialties and Experience: Clinical Development / Translational Medicine / Translational Product Development neuropsychopharmacology – neurodegenerative diseases – CNS therapeutics cardiovascular medicine, vascular biology, angiogenesis, atherosclerosis, cardiometabolic risk biotechnology, pharmacology, drug development, molecular medicine regenerative medicine, tissue engineering medtech, medical devices, device-pharma interfaces, drug delivery systems highly medically-rationaled nutraceuticals venture capital business development medical & clinical affairs
Biovasc, Inc.
View- Website:
- biovasc.com
- Employees:
- 2
-
Managing Partner | Fractional Chief Medical Officer (Fcmo) And Head Of Clinical DevelopmentBiovasc, Inc.San Francisco, Ca, Us
-
Managing Partner/Head Of Clinical DevelopmentBiovasc, Inc. Jun 2003 - PresentSan Francisco, Ca, UsClinical Development specialist for biopharma/biotech SponsorsStartup incubator/accelerator for emerging BioPharma | Biotech | Medtech | Nutratech companies• Product development, alliances, fundraising and consulting in biomedicine and healthcare• Strong internal development and spinout program within key Life Sciences and Healthcare domainsSuccessfully completed numerous Phase 1 through advanced Phase 2 studies ★ Achieving Proof of Concept objectives in patients (huPOC), across multiple clinical indications• clinical strategy, protocol development, clinical safety surveillance and medical monitoring• data analysis, reporting, follow-up• medical contributions to CSR, presentations, peer-reviewed publications• KME/KOL interface, support in-house cross-functional teams and partnersClinical Development Consultant/Contract Medical Director with companies including MycoMedica Life Sciences (Shelton WA), XWPharma (Redwood City CA), PharmaDirections Inc (Cary NC), Theravance Biopharma (South San Francisco CA), Avanir Pharmaceuticals/ (Aliso Viejo CA) and Otsuka Pharma Co US (Princeton NJ).
-
Clinical Development – Consultant | Contract Medical DirectorMycomedica Life Sciences, Pbc Sep 2022 - PresentOrange County And Marin County, California, UsClinical stage biopharmaceutical company with a mission to revolutionize the development of a new class of safe and efficacious psychedelic medications for mental health and neurodegenerative disorders. -
Clinical Development – Consultant | Contract Medical DirectorPharmadirections May 2023 - PresentCary, Nc, Us -
Clinical Development – Consultant | Contract Medical DirectorXwpharma Feb 2018 - PresentBay Area, Ca, UsClinical stage biopharmaceutical company dedicated to the discovery and development of CNS therapeutics applying novel platform chemistry to time-regulated neurobiology. -
Clinical Development – Consultant | Contract Medical DirectorTheravance Biopharma Us, Inc. May 2012 - Oct 2022South San Francisco, Ca, Us -
Clinical Development – Consultant | Contract Medical DirectorAvanir Pharmaceuticals Jan 2019 - Apr 2022Aliso Viejo, Ca, Us -
Scientific And Clinical Advisory BoardElliptical Therapeutics, Llc Aug 2015 - Aug 2019Elliptical Therapeutics is an emerging company using off-patent non-opioid, non-narcotic drugs in improved formulations and delivery modalities to treat pain. [ellipticaltherapeutics.com]
-
Medical Director And Head Of Translational MedicineCyterion Inc. Aug 2011 - Sep 2013Regenerative Medicine company developing gene and cell therapy medicines targeting skin and tissues damaged due to complications from diabetes.
-
Venture PartnerElliptical Ventures Jan 2007 - Jun 2012Venture capital for emerging life science and healthcare companies.
-
Director Of Medical AffairsDiadexus Inc. Jun 2009 - Jul 2011Medical Director of publically-traded company focused on the development and commercialization of proprietary cardiovascular diagnostic products and advanced cardiac biomarkers, with international distribution of the PLAC Test®. -
Vice President, Pharmaceutical Product DevelopmentMedlogics Device Corporation Feb 2004 - Jan 2009UsResponsible for pharmaceutical R&D, product development, preclinical and clinical aspects of Medlogics' cardiovascular drug+device product development. Focus on interventional cardiology and next generation DES. -
Director Of Science & TechnologyMedlogics Device Corporation Feb 2004 - Jun 2007Us
-
Vp Product DevelopmentOsteogenix, Inc. 2005 - 2006Innovative osteobiologics company developing new therapeutics for bone repair and diseases utilizing a “molecular orthopedics” platform. Acquired by Medtronic [MDT].
-
Head Of Technology, Chief Medical Officer, Founding CeoAngiogenix, Inc. (Burlingame Ca) May 1998 - Jun 2003New cardiovascular therapeutics for ischemic diseases
-
Project LeaderJohnson & Johnson (Formerly Cygnus) 1988 - 1990New Brunswick, Nj, UsSustained release drug delivery systems, transdermals
Ken Colley Skills
Ken Colley Education Details
-
Stanford UniversityBiological Sciences -
Georgetown University School Of MedicineMedicine And Molecular Pharmacology
-
The Johns Hopkins University School Of MedicineInternal Medicine
-
William Penn Charter SchoolHs Diploma
Frequently Asked Questions about Ken Colley
What company does Ken Colley work for?
Ken Colley works for Biovasc, Inc.
What is Ken Colley's role at the current company?
Ken Colley's current role is Managing Partner | Fractional Chief Medical Officer (fCMO) and Head of Clinical Development.
What is Ken Colley's email address?
Ken Colley's email address is kc****@****nce.com
What schools did Ken Colley attend?
Ken Colley attended Stanford University, Georgetown University School Of Medicine, The Johns Hopkins University School Of Medicine, William Penn Charter School.
What skills is Ken Colley known for?
Ken Colley has skills like Clinical Development, Biotechnology, Drug Development, Medical Devices, Life Sciences, Pharmacology, Clinical Research, Lifesciences, Start Ups, Commercialization, Translational Medicine, Drug Delivery.
Who are Ken Colley's colleagues?
Ken Colley's colleagues are Thiago Barbosa.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial